Cocaine- and Amphetamine-regulated Transcript (CART) Peptide and the Mesolimbic and Nigrostriatal Dopaminergic Systems
Tài liệu tham khảo
Spiess, 1981, Isolation and sequence analysis of a somatostatin-like polypeptide from ovine hypothalamus, Biochemistry, 20, 1982, 10.1021/bi00510a038
Douglass, 1995, PCR differential display identifies a rat brain mRNA that is transcriptionally regulated by cocaine and amphetamine, J Neurosci, 15, 2471, 10.1523/JNEUROSCI.15-03-02471.1995
Hurd, 1999, The role of dopamine, dynorphin, and CART systems in the ventral striatum and amygdala in cocaine abuse, Ann N Y Acad Sci, 877, 499, 10.1111/j.1749-6632.1999.tb09285.x
Vrang, 2002, Cocaine-amphetamine regulated transcript (CART) expression is not regulated by amphetamine, Neuroreport, 13, 1215, 10.1097/00001756-200207020-00029
Smith, 1997, Ultrastructural localization of CART (cocaine- and amphetamine-regulated transcript) peptides in the nucleus accumbens of monkeys, Synapse, 27, 90, 10.1002/(SICI)1098-2396(199709)27:1<90::AID-SYN10>3.0.CO;2-V
Lakatos, 2005, Cocaine- and amphetamine-regulated transcript (CART) peptide activates the extracellular signal-regulated kinase (ERK) pathway in AtT20 cells via putative G-protein coupled receptors, Neurosci Lett, 384, 198, 10.1016/j.neulet.2005.04.072
Vicentic, 2005, CART (cocaine- and amphetamine-regulated transcript) peptide receptors: specific binding in AtT20 cells, Eur J Pharmacol, 528, 188, 10.1016/j.ejphar.2005.11.041
Jones, 2008, CART receptor binding in primary cell cultures of the rat nucleus accumbens, Synapse, 62, 122, 10.1002/syn.20476
Kuhar, 1999, CART peptides: novel addiction- and feeding-related neuropeptides, Trends Neurosci, 22, 316, 10.1016/S0166-2236(98)01377-0
Kuhar, 2000, CART peptides, Regul Pept, 89, 1, 10.1016/S0167-0115(00)00096-3
Adams, 1999, CART: from gene to function, Brain Res, 848, 137, 10.1016/S0006-8993(99)01907-1
Thim, 1998, CART, a new anorectic peptide, Int J Biochem Cell Biol, 30, 1281, 10.1016/S1357-2725(98)00110-1
Smith, 1999, CART peptideimmunoreactive neurones in the nucleus accumbens in monkeys: ultrastructural analysis, colocalization studies, and synaptic interactions with dopaminergic afferents, J Comp Neurol, 407, 491, 10.1002/(SICI)1096-9861(19990517)407:4<491::AID-CNE3>3.0.CO;2-0
Dallvechia-Adams, 2001, CART peptideimmunoreactive projection from the nucleus accumbens targets substantia nigra pars reticulata neurons in the rat, J Comp Neurol, 434, 29, 10.1002/cne.1162
Couceyro, 1997, Further studies on the anatomical distribution of CART by in situ hybridization, J Chem Neuroanat, 12, 229, 10.1016/S0891-0618(97)00212-3
Koylu, 1997, Immunohistochemical localization of novel CART peptides in rat hypothalamus, pituitary and adrenal gland, J Neuroendocrinol, 9, 823, 10.1046/j.1365-2826.1997.00651.x
Koylu, 1998, Cocaine- and amphetamine-regulated transcript peptide immunohistochemical localization in the rat brain, J Comp Neurol, 391, 115, 10.1002/(SICI)1096-9861(19980202)391:1<115::AID-CNE10>3.0.CO;2-X
Dall Vechia, 2000, CART peptide immunoreactivity in the hypothalamus and pituitary in monkeys: analysis of ultrastructural features and synaptic connections in the paraventricular nucleus, J Comp Neurol, 416, 291, 10.1002/(SICI)1096-9861(20000117)416:3<291::AID-CNE2>3.0.CO;2-E
Elias, 2001, Characterization of CART neurons in the rat and human hypothalamus, J Comp Neurol, 432, 1, 10.1002/cne.1085
Dallvechia-Adams, 2002, Cocaine- and amphetamine-regulated transcript peptide projections in the ventral midbrain: colocalization with gamma-aminobutyric acid, melanin-concentrating hormone, dynorphin, and synaptic interactions with dopamine neurons, J Comp Neurol, 448, 360, 10.1002/cne.10268
Kimmel, 2000, Intra-ventral tegmental area injection of rat cocaine and amphetamine-regulated transcript peptide 55-102 induces locomotor activity and promotes conditioned place preference, J Pharmacol Exp Ther, 294, 784
Jaworski, 2003, Intra-accumbal injection of CART (cocaine-amphetamine regulated transcript) peptide reduces cocaine-induced locomotor activity, J Pharmacol Exp Ther, 307, 1038, 10.1124/jpet.103.052332
Jaworski, 2003, CART peptides are modulators of mesolimbic dopamine and psychostimulants, Life Sci, 73, 741, 10.1016/S0024-3205(03)00394-1
Shieh, 2003, Effects of the cocaine- and amphetamine-regulated transcript peptide on the turnover of central dopaminergic neurons, Neuropharmacology, 44, 940, 10.1016/S0028-3908(03)00095-9
Yang, 2004, CART peptide increases the mesolimbic dopaminergic neuronal activity: a microdialysis study, Eur J Pharmacol, 494, 179, 10.1016/j.ejphar.2004.05.018
Yang, 2005, Differential effects of melanin concentrating hormone on the central dopaminergic neurons induced by the cocaine- and amphetamine-regulated transcript peptide, J Neurochem, 92, 637, 10.1111/j.1471-4159.2004.02896.x
Yang, 2007, Gonadal hormones-mediated effects on the stimulation of dopamine turnover in mesolimbic and nigrostriatal systems by cocaine- and amphetamine-regulated transcript (CART) peptide in male rats, Neuropharmacology, 53, 801, 10.1016/j.neuropharm.2007.08.007
Shieh, 2008, Effects of estradiol on the stimulation of dopamine turnover in mesolimbic and nigrostriatal systems by cocaine- and amphetamine-regulated transcript peptide in female rats, Neuroscience, 154, 1589, 10.1016/j.neuroscience.2008.01.086
Hurd, 2000, Human cocaine- and amphetamineregulated transcript (CART) mRNA is highly expressed in limbic- and sensory-related brain regions, J Comp Neurol, 425, 583, 10.1002/1096-9861(20001002)425:4<583::AID-CNE8>3.0.CO;2-#
Marie-Claire, 2003, Fos but not Cart (cocaine and amphetamine regulated transcript) is overexpressed by several drugs of abuse: a comparative study using real-time quantitative polymerase chain reaction in rat brain, Neurosci Lett, 345, 77, 10.1016/S0304-3940(03)00307-0
Yang, 2004, Effects of the cocaine- and amphetamineregulated transcript peptide on the turnover of dopamine in tuberoinfundibular neurons and serum prolactin levels: studies using estrogen, melanin concentrating hormone, and melanocortin, Neuropharmacology, 47, 1070, 10.1016/j.neuropharm.2004.06.028